NCT07463716

Brief Summary

The goal of this randomized cross-over study is to investigate whether the design of non-invasive ventilation (NIV) mask impacts respiratory variables in healthy volunteers on NIV therapy. The main questions it aims to answer are:

  • To assess if mask design impacts the ventilatory ratio in healthy volunteers.
  • To assess if mask design impacts transcutaneous CO2, respiratory rate, and tidal volume in healthy volunteers. Participants will attend five study visits:
  • Visit 1. Participants will be fitted to use non-invasive ventilation briefly to acclimatize them to using the therapy.
  • Visit 2. Participants will receive NIV with one of four masks. They will be asked to breathe through their mouth or through their nose, with a break from NIV in between the two sessions of NIV.
  • Visits 3-5. Participants will receive NIV with one of the other three masks, repeating Visit 2.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable healthy-volunteers

Timeline
0mo left

Started Mar 2026

Shorter than P25 for not_applicable healthy-volunteers

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Mar 2026Jun 2026

Study Start

First participant enrolled

March 1, 2026

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

March 2, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 11, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

March 11, 2026

Status Verified

March 1, 2026

Enrollment Period

2 months

First QC Date

March 2, 2026

Last Update Submit

March 5, 2026

Conditions

Keywords

Noninvasive ventilationPulmonary

Outcome Measures

Primary Outcomes (1)

  • Change in ventilatory ratio

    To assess if mask design can reduce ventilatory ration in healthy volunteers

    15 minutes

Secondary Outcomes (3)

  • Change in transcutaneous carbon dioxide (CO2)

    15 minutes

  • Change in respiratory rate

    15 minutes

  • Change in tidal volume

    15 minutes

Study Arms (8)

NIV using Mask A, with mouth-open

EXPERIMENTAL

Mask A is the investigational mask

Device: Non-invasive ventilation (NIV)

NIV using Mask A, with mouth-closed

EXPERIMENTAL

Mask A is the investigational mask

Device: Non-invasive ventilation (NIV)

NIV using Mask B, with mouth-open

ACTIVE COMPARATOR

Mask B is a comparator mask

Device: Non-invasive ventilation (NIV)

NIV using Mask B, with mouth-closed

ACTIVE COMPARATOR

Mask B is a comparator mask

Device: Non-invasive ventilation (NIV)

NIV using Mask C, with mouth-open

ACTIVE COMPARATOR

Mask C is a comparator mask

Device: Non-invasive ventilation (NIV)

NIV using Mask C, with mouth-closed

ACTIVE COMPARATOR

Mask C is a comparator mask

Device: Non-invasive ventilation (NIV)

NIV using Mask D, with mouth-open

ACTIVE COMPARATOR

Mask D is a comparator mask

Device: Non-invasive ventilation (NIV)

NIV using Mask D, with mouth-closed

ACTIVE COMPARATOR

Mask D is a comparator mask

Device: Non-invasive ventilation (NIV)

Interventions

Delivery of positive airway pressure to the lungs via an interface, such as a mask

NIV using Mask A, with mouth-closedNIV using Mask A, with mouth-openNIV using Mask B, with mouth-closedNIV using Mask B, with mouth-openNIV using Mask C, with mouth-closedNIV using Mask C, with mouth-openNIV using Mask D, with mouth-closedNIV using Mask D, with mouth-open

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or over
  • Able to give informed consent

You may not qualify if:

  • Unable to tolerate non-invasive ventilation (NIV)
  • Unable to adequately fit an NIV mask
  • Claustrophobia while using NIV
  • Symptoms of cold or flu (including COVID-19) in previous twenty-four hours
  • Chronic Rhinitis or self-reported history of upper airway obstruction
  • Pneumothorax or history of previous pneumothorax
  • Employee in the NIV team at Fisher \& Paykel Healthcare

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Noninvasive Ventilation

Intervention Hierarchy (Ancestors)

Respiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • William Good, Medical degree

    Middlemore Hospital, New Zealand

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcomes Assessor
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Randomized, cross-over, non-blinded
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 2, 2026

First Posted

March 11, 2026

Study Start

March 1, 2026

Primary Completion

May 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

March 11, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

All data to be deidentified